Skip to content

Evaluation of a Novel Technique to Diagnose Carotid Artery Stenosis

Evaluation of a Novel Technique to Diagnose Carotid Artery Stenosis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03464851
Enrollment
51
Registered
2018-03-14
Start date
2018-03-08
Completion date
2020-02-01
Last updated
2020-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Stenosis

Keywords

carotid artery stenosis, plaque, carotid duplex, ultrasound, fibromsucular dysplasia, carotid atherosclerosis

Brief summary

The purpose of this study is to determine the accuracy of a new non-invasive device, the Carotid Stenotic Scan (CSS), to check for stenosis of the internal carotid artery (ICA) as compared to a carotid ultrasound study.

Detailed description

Currently, carotid duplex ultrasound is used for screening for ICA stenosis and must be performed by a trained and certified vascular technologist using advanced duplex imaging equipment and with subsequent interpretation by a trained physician. It would be of value to develop an accurate, reliable, low-cost, and easily accessible tool to screen for extra-cranial ICA disease in an office based setting. However, such a tool would require novel technology that allows for quick, accurate, reproducible, and safe evaluation. This study will evaluate a new technology called the Carotid Stenotic Scan (CSS) developed by CVR Global. The CSS instrument uses principles of cardiovascular resonance to detect low frequency pressure fluctuations associated with flow disturbances in areas of significant arterial narrowing. Subjects will undergo a clinically ordered clinical carotid duplex ultrasound as part of standard of care. Subjects will have a noninvasive CSS assessment before or after the carotid duplex ultrasound. Within 3 months following the date of the initial study visit, the electronic medical record will be queried for any interval correlative imaging studies (CTA, MRA, or angiography) and reports performed up to 1 month prior and 3 months after the duplex examination date. Report of findings will be documented (i.e., % ICA stenosis by CTA/MRA).

Interventions

DIAGNOSTIC_TESTCarotid Stenotic Scan (CSS)

Placement of the CSS instrument on the carotid arteries to measure degree of stenosis of the carotid artery. The CSS scan takes about 1-2 minutes to gather data for real-time analysis by the processor on the device cart.

Sponsors

CVR Global, Inc.
CollaboratorINDUSTRY
The Cleveland Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Outpatients age \> 18 years sent to the vascular laboratory for carotid duplex examination for initial carotid ultrasound study or for follow-up of known carotid disease. * Enrolled patients will include at least 100 subjects with at least moderate known stenosis (50-69% or greater, PSV \> 125 cm/sec) or occlusion of one or both ICAs * Up to 25 patients with known fibromuscular dysplasia (FMD) of the internal carotid arteries.

Exclusion criteria

* Age \< 18 years. * Hospitalized inpatients. * Inability to provide informed consent. * Prior history of carotid endarterectomy or carotid artery stent. * Prior neck surgery * Known prosthetic heart valve, known critical aortic stenosis, or study indication preop open heart or aortic surgery.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of CSS readings to conventional carotid artery duplex ultrasoundBaselinePrimary analysis % agreement CSS and carotid duplex ultrasound (SRUCC interpretation) for ICA stenosis

Secondary

MeasureTime frameDescription
Reproducibility of the CSS measurementBaselineEach CSS measurement will be repeated and the Intraclass Correlation Coefficient (ICC) will be calculated. The ICC in an index of the reliability of measurements from the same operator

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026